Rushee Jolly

Rushee Jolly is a Global Product Leader specializing in gastric, lung, and other tumors at AstraZeneca. With a robust background in oncology strategy and drug development, Rushee's past experience includes significant roles at Ernst & Young and Sanford C. Bernstein & Co., LLC, where they excelled in life sciences and EU pharma equity research. They hold a PhD and MSc in Neuroscience and a BSc in Pharmacology, and are also a Chartered Financial Analyst (CFA) charterholder and ACA qualified Chartered Accountant.